FibroGen Inc (FGEN) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.00x

FibroGen Inc (FGEN) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $26.00K (capex $13.00K plus investments $-13.00K) from operating cash flow of $12.68 Million. Explore FGEN capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$26.00K
Capex + Investments

Operating Cash Flow

$12.68 Million
USD

Capital Expenditures

$13.00K
USD

FibroGen Inc Cash Flow Reinvestment Rate (2013–2020)

Historical reinvestment intensity for FibroGen Inc across 4 annual periods. Also explore FGEN current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for FibroGen Inc (2013–2020)

Year-by-year capital reinvestment analysis for FibroGen Inc. For live market cap and broader valuation context, see FibroGen Inc (FGEN) market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 5.78x $471.50 Million $81.60 Million $3.99 Million ▲ +350.0%
2016 1.28x $9.13 Million $7.11 Million $1.25 Million ▼ -73.2%
2014 4.79x $107.30 Million $22.41 Million $8.12 Million ▲ +1723.0%
2013 0.26x $6.81 Million $25.92 Million $6.81 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow